All Posts: aging
-
“SNIFF,” a Nasal Insulin Study for Alzheimer’s, Now Underway at Georgetown
WASHINGTON – Georgetown University’s Memory Disorders Program is looking for volunteers to participate in a study to see if insulin, the hormone used to treat diabetes, can improve cognition, memory and daily function in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease.
Category: News Release
-
Georgetown Study Opens for Those With Inherited Genetic Risk for Alzheimer’s Disease
WASHINGTON — The Memory Disorders Program at Georgetown University Medical Center is seeking volunteers to participate in a study testing two agents to slow the onset and progression of Alzheimer’s disease. Cognitively normal individuals with a particular genetic risk of developing the disorder are being sought.
Category: News Release
-
First Diagnosed Case of Alzheimer’s Disease in HIV-Positive Individual Reported
WASHINGTON (April 15, 2016) — Georgetown University researchers are reporting the first case of Alzheimer’s disease diagnosed in an HIV-positive individual. The finding in a 71-year-old man triggers a realization about HIV survivors now reaching the age when Alzheimer’s risk begins to escalate. Published online in the open access journal Alzheimer’s & Dementia: Diagnosis, Assessment & Disease […]
Category: News Release
-
Researcher Debunks Alzheimer's Prevailing Development Theory
(October 31, 2014) – New research that dramatically alters the prevailing theory of how Alzheimer’s disease develops has been published online today by Georgetown researchers in the journal Molecular Neurodegeneration. The research also helps explains why some people with plaque buildup in their brains don’t develop dementia, and shows the potential of a cancer drug […]
Category: GUMC Stories